114 related articles for article (PubMed ID: 23179147)
21. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Moon KC
Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
[TBL] [Abstract][Full Text] [Related]
23. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
24. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
[TBL] [Abstract][Full Text] [Related]
25. Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
Wang JY; Fang M; Boye A; Wu C; Wu JJ; Ma Y; Hou S; Kan Y; Yang Y
Oncotarget; 2017 Oct; 8(49):84958-84973. PubMed ID: 29156696
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of p21 and p53 expression in gastric cancer.
Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
[TBL] [Abstract][Full Text] [Related]
27. Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers.
Ananiev J; Gulubova M; Tchernev G; Penkova M; Miteva R; Julianov A; Manolova I
Wien Klin Wochenschr; 2011 Nov; 123(21-22):668-73. PubMed ID: 22015652
[TBL] [Abstract][Full Text] [Related]
28. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
29. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
Wang J; Dong Y; Wang X; Ma H; Sheng Z; Li G; Lu G; Sugimura H; Zhou X
Oncol Rep; 2010 Dec; 24(6):1577-84. PubMed ID: 21042754
[TBL] [Abstract][Full Text] [Related]
30. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
[TBL] [Abstract][Full Text] [Related]
31. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
Nakamura N; Yoshida K; Tsuda R; Murata M; Yamaguchi T; Suwa K; Ichimura M; Tsuneyama K; Matsuzaki K; Nakano T; Hirohara J; Seki T; Okazaki K; Gershwin ME; Naganuma M
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1480-1492. PubMed ID: 34994163
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of thymidylate synthase expression in gastric carcinoma: correlation with clinicopathological parameters and survival.
Rogoza-Mateja W; Domagala P; Kaczmarczyk M; Mieżyńska-Kurtycz J; Ławniczak M; Sulżyc-Bielicka V; Bielicki D; Karpińska-Kaczmarczyk K; Domagala W
Histol Histopathol; 2017 Feb; 32(2):193-201. PubMed ID: 27240805
[TBL] [Abstract][Full Text] [Related]
34. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H; Takahashi H; Nakajima T; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Dec; 132(12):817-23. PubMed ID: 16807756
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of CD168 expression in gastric cancer.
Ishigami S; Ueno S; Nishizono Y; Matsumoto M; Kurahara H; Arigami T; Uchikado Y; Setoyama T; Arima H; Yoshiaki K; Kijima Y; Kitazono M; Natsugoe S
BMC Cancer; 2011 Mar; 11():106. PubMed ID: 21435222
[TBL] [Abstract][Full Text] [Related]
36. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma.
Sha S; Gu Y; Xu B; Hu H; Yang Y; Kong X; Wu K
Dig Liver Dis; 2013 May; 45(5):422-9. PubMed ID: 23332081
[TBL] [Abstract][Full Text] [Related]
38. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
39. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
Shareef MM; Radi DM; Eid AM
Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
